Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Baxter
Express Scripts
Moodys
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for SCY-635

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug SCY-635: Patents, clinical trial progress, indications

SCY-635 is an investigational drug.

There have been 12 clinical trials for SCY-635. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2019.

The most common disease conditions in clinical trials are Candidiasis, Candidiasis, Vulvovaginal, and Vulvovaginitis. The leading clinical trial sponsors are Scynexis, Inc., Clinical Network Services (CNS) Pty Ltd, and PPD.

There are six US patents protecting this investigational drug and two hundred and four international patents.

Recent Clinical Trials for SCY-635
TitleSponsorPhase
Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy SubjectsClinical Network Services (CNS) Pty LtdPhase 1
Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy SubjectsScynexis, Inc.Phase 1
Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy SubjectsClinical Network Services (CNS) Pty LtdPhase 1

See all SCY-635 clinical trials

Clinical Trial Summary for SCY-635

Top disease conditions for SCY-635
Top clinical trial sponsors for SCY-635

See all SCY-635 clinical trials

US Patents for SCY-635

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SCY-635   Start Trial Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection VOLANT HOLDINGS GMBH (CH) THERABRAKE, INC. (Eggertsville, NY)   Start Trial
SCY-635   Start Trial Modulators of pharmacokinetic properties of therapeutics Gilead Sciences, Inc. (Foster City, CA)   Start Trial
SCY-635   Start Trial Antiviral compounds Gilead Sciences, Inc. (Foster City, CA)   Start Trial
SCY-635   Start Trial Heterocyclic flaviviridae virus inhibitors Gilead Sciences, Inc. (Foster City, CA)   Start Trial
SCY-635   Start Trial Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection VOLANT HOLDINGS GMBH (Feusisberg, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SCY-635

Drugname Country Document Number Estimated Expiration Related US Patent
SCY-635 African Regional IP Organization (ARIPO) 2985 2026-07-07   Start Trial
SCY-635 African Regional IP Organization (ARIPO) 2986 2026-07-07   Start Trial
SCY-635 African Regional IP Organization (ARIPO) 3915 2026-07-07   Start Trial
SCY-635 Argentina 061838 2026-07-07   Start Trial
SCY-635 Argentina 065439 2026-07-07   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Boehringer Ingelheim
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.